David R Rosenberg

Clinical relevance of the use of Dentoxol® for oral mucositis induced by radiotherapy: A phase II clinical trial

J. Oyarzún, N. Jara, C. Carvajal, 2022, World journal of clinical oncology.

Efficacy and safety of Dentoxol® in the prevention of radiation-induced oral mucositis in head and neck cancer patients (ESDOM): a randomized, multicenter, double-blind, placebo-controlled, phase II trial

R. Feinn, R. Lalla, P. Bettoli, 2020, Supportive Care in Cancer.

Interaction between Different Implant Surfaces and Liquid Fibrinogen: A Pilot In Vitro Experiment

M. Quirynen, N. Pinto, Catherine X Andrade, 2021, BioMed research international.

Short-term effects of 2% atorvastatin dentifrice as an adjunct to periodontal therapy: a randomized double-masked clinical trial.

J. Nart, A. Chaparro, V. Ramirez, 2015, Journal of periodontology.

Association between the use of statins and periodontal status: a review

J. Nart, A. Chaparro, Jeremy R Kernitsky, 2019, Revista clínica de periodoncia implantología y rehabilitación oral.

Atorvastatin-Medicated Dentifrice Significantly Inhibits CD 4 + T Cell Proliferation : In vitro Pilot Study

J. Nart, V. Ramirez, Jeremy R Kernitsky, 2017 .